Clinical Trial

Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients.

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.
Trial Details
NCT Number NCT07208604
Lead Sponsor TECLens, Inc.
Collaborators: Robert Ang, MD, Robert Ang, MD - Asian Eye Institute
Conditions Presbyopia
Enrollment 25 participants
Start Date 2025-09-30
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-10-06